Does MITOTANE Cause Malignant neoplasm progression? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Malignant neoplasm progression have been filed in association with MITOTANE (Lysodren). This represents 6.0% of all adverse event reports for MITOTANE.
61
Reports of Malignant neoplasm progression with MITOTANE
6.0%
of all MITOTANE reports
15
Deaths
14
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MITOTANE?
Of the 61 reports, 15 (24.6%) resulted in death, 14 (23.0%) required hospitalization, and 5 (8.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOTANE. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does MITOTANE Cause?
Nausea (210)
Fatigue (205)
Off label use (154)
Diarrhoea (123)
Vomiting (97)
Drug ineffective (86)
Decreased appetite (77)
Adrenal insufficiency (76)
Dizziness (76)
Asthenia (70)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MITOTANE Alternatives Have Lower Malignant neoplasm progression Risk?
MITOTANE vs MITOXANTRONE
MITOTANE vs MITRAGYNINE\HERBALS
MITOTANE vs MIZORIBINE
MITOTANE vs MOBOCERTINIB
MITOTANE vs MOCLOBEMIDE